False elevation of tumor markers: Chromogranin a and gastrin due to use of proton pump inhibitors (CROSBI ID 720919)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Vidranski, Valentina ; Krilić, Dražena ; Ladika Davidović, Blaženka ; Periša, Josipa ; Mlakar Pedišić, Irena ; Šamija, Ivan
engleski
False elevation of tumor markers: Chromogranin a and gastrin due to use of proton pump inhibitors
Patients on proton pump inhibitors (PPI) therapy had significantly higher fasting serum gastrin and CgA. False positive elevation of markers can lead to misinterpretation of laboratory test results and thus to misdiagnosis or course of oncology monitoring. Patients should be asked before blood sampling blood for CgA and gastrin, if they are taking PPI and, in collaboration with clinicians, have their blood sampled 4 days after stopping the drug.
Chromogranin a ; gastrin ; proton pump inhibitors
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
S416-S417.
2022.
nije evidentirano
objavljeno
10.1016/j.cca.2022.04.450
Podaci o matičnoj publikaciji
Clinica chimica acta
Elsevier
0009-8981
1873-3492
Podaci o skupu
24th International Congress of Clinical Chemistry and Laboratory Medicine (IFCC WorldLab Seoul 2022) ; 16th Asia-Pacific Congress of Clinical Biochemistry (16th APFCB)
poster
26.06.2022-30.06.2022
Seoul, Republika Koreja
Povezanost rada
Kliničke medicinske znanosti